CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations
- 10-K Report Annual Report
- SC 13G Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award EVP & Chief Business Officer acquired 18,975 shares (grant or award)
- 4 Grant or award EVP & Chief Financial Officer acquired 18,975 shares (grant or award)
- 4 Open-market sale President & CEO sold 6,571 shares at $5.87 ($38,564)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale EVP & Chief Business Officer sold 1,645 shares at an average $6.30 ($10,368)
- 4 Open-market sale EVP & Chief Financial Officer sold 1,908 shares at an average $6.31 ($12,035)
- 4 Open-market buy Director bought 2,647,058 shares at $6.80 ($17,999,994)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
Page 16 of 27 · 524 filings